Ping An Healthcare and Technology Company (1833) AI Stock Analysis

• Market Cap: HK$17.53B
• Dividend Yield: N/A
• Average Volume (3M): 7.98M
• Price to Earnings (P/E): 96.3
• Beta (1Y): 1.40
• Revenue Growth: 1.01%
• EPS Growth: N/A
• Country: HK
• Employees: 1,563
• Sector: Healthcare
• Sector Strength: 58
• Industry: Medical - Healthcare Information Services
• EPS (TTM): N/A
• Shares Outstanding: 2,161,443,600
• 10 Day Avg. Volume: 12,218,410
• 30 Day Avg. Volume: 7,981,170
• PEG Ratio: 0.56
• Price to Book (P/B): 1.51
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -24.06
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: HK$10.99
• Price Target Upside: 41.42% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 51 Neutral
• Price Target: HK$8.00 ▲(2.96%Upside)

The overall score for Ping An Healthcare and Technology Company is primarily driven by mixed financial performance and positive technical indicators. Despite strong cash reserves and technical strength, high valuation and inconsistent profitability pose significant risks.

Ping An Healthcare and Technology Company Business Overview & Revenue Model

Company Description

Ping An Healthcare and Technology Company Limited, commonly known as Ping An Good Doctor, operates as a leading technology-driven healthcare service provider in China. The company is a subsidiary of Ping An Insurance Group, one of the largest financial services conglomerates in the world. Ping An Healthcare offers a comprehensive range of healthcare services through its online platform, including online medical consultations, hospital referrals, health management, and wellness interaction. The platform integrates artificial intelligence and big data technologies to deliver personalized and efficient healthcare solutions to its users.

How the Company Makes Money

Ping An Healthcare and Technology Company primarily generates revenue through its online healthcare services platform, Ping An Good Doctor. The company's key revenue streams include online medical services, which involve fees from consultations and health management services. Additionally, Ping An Good Doctor earns from partnerships with hospitals and healthcare providers for facilitating patient referrals and appointments. The company also generates income from its health mall, offering pharmaceutical and wellness products, and from its advertising and membership services. Strategic partnerships with healthcare institutions and leveraging Ping An Group's vast insurance network further bolster its revenue by driving user traffic and enhancing service offerings.

Ping An Healthcare and Technology Company Financial Statement Overview

Summary

Ping An Healthcare and Technology Company displays mixed financial health. While there are positive signs in cash reserves and recent profitability improvements, the company faces challenges with maintaining consistent revenue growth and profitability. The balance sheet remains robust with low leverage, but operational efficiency needs to be enhanced to support sustainable growth.

Income Statement

The company shows a concerning trend in profitability with negative EBIT and EBITDA margins over the years. However, there is a recent improvement in net income, indicating potential recovery. The gross profit margin remains healthy, but revenue growth has been volatile, signaling uncertainty in financial performance.

Balance Sheet

The company maintains strong cash reserves as indicated by the substantial cash and short-term investments. The debt-to-equity ratio is low, suggesting conservative use of leverage. However, the return on equity is weak due to inconsistent net income, which could be a potential risk if profitability does not stabilize.

Cash Flow

There is a positive shift in operating cash flow, moving from negative to positive, suggesting improvement in cash generation. However, free cash flow remains inconsistent, which could impact future investments. The free cash flow to net income ratio shows improvement, but overall cash flow stability needs attention.

Breakdown
Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
4.81B	4.67B	6.16B	7.33B	6.87B
	Gross Profit
1.52B	1.51B	1.68B	1.71B	1.86B
	EBIT
-89.06M	-575.26M	-1.09B	-1.84B	-681.63M
	EBITDA
193.43M	-164.23M	-1.02B	-1.76B	-605.20M
	Net Income Common Stockholders
81.43M	-322.59M	-607.57M	-1.54B	-948.48M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
11.52B	11.42B	10.14B	10.14B	13.53B
	Total Assets
16.78B	16.52B	17.14B	17.88B	18.56B
	Total Debt
45.00M	93.61M	176.49M	201.29M	113.97M
	Net Debt
-2.00B	-1.77B	-3.52B	-2.86B	-7.81B
	Total Liabilities
13.20B	3.25B	3.68B	3.79B	2.71B
	Stockholders Equity
3.59B	13.28B	13.46B	14.08B	15.83B
Cash Flow		Free Cash Flow
65.08M	-325.82M	-845.05M	-1.49B	-1.18B
	Operating Cash Flow
99.33M	-282.86M	-810.62M	-1.40B	-1.10B
	Investing Cash Flow
114.65M	-1.49B	1.71B	-3.10B	-2.50B
	Financing Cash Flow
-38.44M	-67.36M	-317.88M	-319.91M	6.92B

Ping An Healthcare and Technology Company Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 7.77
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1833, the sentiment is Positive. The current price of 7.77 is above the 20-day moving average (MA) of 7.11, above the 50-day MA of 7.13, and above the 200-day MA of 6.03, indicating a bullish trend. The MACD of 0.06 indicates Negative momentum. The RSI at 71.11 is Negative, neither overbought nor oversold. The STOCH value of 82.79 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1833.

Ping An Healthcare and Technology Company Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2276	68 Neutral	HK$17.06B	31.91	28.81%	1.49%	14.99%	31.70%
1952	55 Neutral	HK$17.88B	―	-23.03%	―	461.36%	-16.43%
Sector *	54 Neutral	$5.41B	3.27	-45.10%	3.29%	16.81%	0.02%
1833	51 Neutral	HK$17.53B	96.28	0.96%	―	1.01%	―
2159	46 Neutral	HK$95.00M	―	-48.20%	―	-4.57%	52.37%
2158	45 Neutral	HK$6.21B	―	-4.01%	―	11.00%	56.87%
2251	30 Underperform	HK$1.61B	―	-18.19%	―	-24.50%	-132.43%

Ping An Healthcare and Technology Company Corporate Events

Ping An Healthcare Announces 2025 AGM Agenda

Ping An Healthcare and Technology Company Limited has announced its upcoming annual general meeting scheduled for June 26, 2025, in Shanghai. Key agenda items include the adoption of the 2024 financial statements, re-election of directors, and appointment of Ernst & Young as the company’s auditor. The meeting will also consider resolutions to authorize the board to manage share allotments and related financial instruments, indicating a strategic focus on financial governance and operational continuity.

The most recent analyst rating on (HK:1833) stock is a Hold with a HK$12.00 price target. To see the full list of analyst forecasts on Ping An Healthcare and Technology Company stock, see the HK:1833 Stock Forecast page.

Ping An Healthcare Announces Auditor Change to Ernst & Young

Ping An Healthcare and Technology Company Limited has announced a proposed change of auditor, with PricewaterhouseCoopers retiring after more than seven years of service. The company plans to appoint Ernst & Young as the new auditor, subject to shareholder approval at the upcoming annual general meeting. This change aims to maintain good corporate governance and ensure the independence and objectivity of the auditing process, aligning with the Corporate Governance Code and benefiting the company and its shareholders.

The most recent analyst rating on (HK:1833) stock is a Hold with a HK$12.00 price target. To see the full list of analyst forecasts on Ping An Healthcare and Technology Company stock, see the HK:1833 Stock Forecast page.

Ping An Healthcare Reports Strong Q1 2025 Growth

Ping An Healthcare and Technology Company Limited reported a significant increase in revenue and profit for the first quarter of 2025, driven by advancements in its corporate health management business and innovative healthcare models. The company achieved a 25.8% rise in revenue and a notable improvement in adjusted net profit, attributed to the expansion of its ‘insurance + health care’ model and the introduction of AI-driven services like ‘Ping An Xin Yi’, which enhances medical service efficiency and quality.

Ping An Healthcare Schedules Board Meeting for Q1 Results

Ping An Healthcare and Technology Company Limited has announced a Board meeting scheduled for April 23, 2025, to review and approve the company’s first quarterly results for the period ending March 31, 2025. This meeting is significant as it will provide insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and stakeholder interests.